Laura Escolà-Vergé

16PUBLICATIONS
48CO-AUTHORS
Medical infection agents (incl. prions)Medical molecular engineering of nucleic acids and proteinsNanotoxicology, health and safetyIndustrial microbiology (incl. biofeedstocks)Medical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Apr 16, 2026
Geographical Differences in the Epidemiology and Treatment of Candida Prosthetic Joint Infections.

|Dec 30, 2025
Targeting Overtreatment of Asymptomatic Bacteriuria in the Emergency Department: Results from a Quasi-Experimental Clinical Pharmacist-Led Program Based on Education and Audit.

Alvaro Monje, Laura Escolà-Vergé, Alba Rivera

|May 21, 2025
Use of teicoplanin monotherapy for the treatment of enterococcal infective endocarditis: a retrospective and comparative study at a referral centre-a counterpoint.

Miguel Villamarín, Núria Fernández-Hidalgo, Laura Escolà-Vergé

|Jan 25, 2025
Correction: Kirkegaard-Biosca et al. Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria. Antibiotics 2024, 13, 874.

Cristina Kirkegaard-Biosca, Ester Del Barrio-Tofiño, Miguel Villamarín

|Jan 08, 2025
Ciprofloxacin for the Treatment of Infections Caused by Carbapenemase-Producing Gram-Negative Bacteria.

Pablo Rubiñan, Belén Viñado, Nuria Fernández-Hidalgo

|Nov 27, 2024
An Update on Recent Clinical Trial Data in Bloodstream Infection.

Adam G Stewart, Peter Simos, Pirathaban Sivabalan

Pageof 3

Frequent Collaborators

7 joint publications

Nuria Fernández-Hidalgo

6 joint publications

Juan José González-López

4 joint publications

Ibai Los-Arcos

3 joint publications

Nieves Larrosa